HistoSonics
Minneapolis, MN, United States · Healthcare · 280 employees
HistoSonics is a growth phase company developing a non-invasive sonic beam therapy platform and procedure using the science of histotripsy. Histotripsy utilizes the pressure created by focused sound energy to liquefy and destroy targeted tissue, including diseased tissue and tumors, at sub-cellular levels. The company’s new platform delivers personalized, tissue specific treatments with precisio
Funding history
- Funding Round — Undisclosed — Jun 2026
- Funding Round — $250.0M — Oct 2025
- Venture - Series Unknown — $102.0M — Aug 2024
- Series D — $102.0M — Aug 2024
- Venture - Series Unknown — $85.0M — Dec 2022
Recent signals
- Jun 22, 2026: Raised funding in Funding Round
- Oct 16, 2025: Raised $250.0M in Funding Round
- Nov 18, 2024: Launched HistoSonics Launches the BOOMBOX Study to Evaluate Histotripsy for Liver Tumors.
- Oct 28, 2024: HistoSonics Awarded $90 Million Contract with Veterans Affairs for Tumor Destroying Histotripsy Systems
- Aug 15, 2024: Raised $102.0M in Venture - Series Unknown
- Aug 15, 2024: Raised $102.0M in Series D
- Dec 27, 2022: Raised $85.0M in Venture - Series Unknown
- Dec 13, 2022: Raised $100.0M in Funding Round
See plans & pricing → Track HistoSonics’s funding, hiring, and signals — with verified contacts — on Fundz.